Community Research and Development Information Service - CORDIS

Dopaminergic partial agonist with potential against both parkinson's disease and psychosis (DOPARTAGO)

From 2003-01-01 to 2004-12-31

Project details

Total cost:

EUR 1 689 900

EU contribution:

EUR 809 900

Coordinated in:

Netherlands

Funding scheme:

CRS - Cooperative research contracts

Coordinator

AXON BIOCHEMICALS B.V.
Netherlands
Elsschotlaan 32
9721 WN GRONINGEN
Netherlands
See on map
Administrative contact: Hakan WIKSTROEM

Participants

ACADIA PHARMACEUTICAS A/S
Denmark
Fabriksparken, 58
2600 GLOSTRUP
Denmark
See on map
Administrative contact: Bo-Ragnar TOLF
APOTEKET AB
Sweden
Prismavagen, 2
14175 KUNGENS KURVA
Sweden
See on map
Administrative contact: Erling EHRIN
INDEPENDENT PHARMACEUTICA AB
Sweden
c/o Revisorspoolen Matsson and Co - Tegnergatan 37
11161 STOCKHOLM
Sweden
See on map
Administrative contact: Torgny SVENSSON
NETHERLANDS RESEARCH SCHOOL FOR ASTRONOMY - LEGALLY REPRESENTED BY UNIVERSITY OF GRONINGEN
Netherlands
5,Broerstraat 5
9712 CP GRONINGEN
Netherlands
See on map
Administrative contact: Andries P. BRUINS
NORDIC SYNTHESIS AB
Sweden
69 85 KARLSKOGA
Sweden
See on map
Administrative contact: Soren OLSSON
SCANTOX
Denmark
Hestehavevej 36 A, Ejby
4623 LILLE SKENSVED
Denmark
See on map
Administrative contact: C. Nicholas EDWARDS
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top